Jon Irvin

BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX.

Voxpath Networks, Inc. manufactures and provides key telephone systems and applications. It also provides advanced PBX system features including direct inward dialing, hunt groups and advanced call forwarding, as well as media applications like advanced voice messaging, virtual receptionist, and call conferencing. The company was founded in 2000 and is located in Austin, TX.

Reddwerks Corp. developed and sells warehouse performance management software and solutions. It managed labor, equipment, and material flow and automates order processing in large-scale distribution facilities. The company was founded by Jean Belanger in 2003 and was headquartered in Austin, TX.

Ernst & Young provides accounting services. Its services include auditing, accounting, tax and transaction services, assurance and advisory business, online transaction advisory and a wide range of financial services. The company was founded by Arthur Young and Alwin C. Ernst in 1881 and is headquartered in Kansas City, MO.

Esoterix, Inc. provides laboratory testing services. The company performs esoteric laboratory tests including testing for asthma, bleeding disorders, cancer, diabetes, and infectious diseases. The company was founded in 1995 and is headquartered in Austin, TX.

TOPAZ Technologies, Ltd. provides animal and human research software solutions for the medical research industry. It offers solutions for operations, compliance, veterinary and information technology. The company was founded in 1979 and is headquartered in Pflugerville, TX.

Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX.